Westlake Chemical Partners LP (WLKP)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 600M 1.2B 1.8B Q3 '21: 1.1B Q4 '21: 1.2B Q1 '22: 1.3B Q2 '22: 1.4B Q3 '22: 1.6B Q4 '22: 1.6B Q1 '23: 1.5B Q2 '23: 1.4B Q3 '23: 1.3B Q4 '23: 1.2B Q1 '24: 1.2B Q2 '24: 1.2B Q3 '24: 1.1B Q4 '24: 1.1B Q1 '25: 1.1B Q2 '25: 1.1B Q3 '25: 1.1B Q4 '25: 1.2B Q1 '26: 1.2B Q2 '26: 1.2B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 200M 400M 600M Q3 '21: 379.6M Q4 '21: 441.7M Q1 '22: 445.4M Q2 '22: 411.7M Q3 '22: 426.3M Q4 '22: 377.4M Q1 '23: 392M Q2 '23: 382.4M Q3 '23: 384.9M Q4 '23: 387.5M Q1 '24: 383.6M Q2 '24: 397.1M Q3 '24: 421M Q4 '24: 418.9M Q1 '25: 370.8M Q2 '25: 367.1M Q3 '25: 349.6M Q4 '25: 347.8M Q1 '26: 387.5M Q2 '26: 384.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

0 150M 300M 450M Q3 '21: 347.5M Q4 '21: 410.7M Q1 '22: 414.9M Q2 '22: 379.5M Q3 '22: 393.2M Q4 '22: 347.7M Q1 '23: 362.6M Q2 '23: 355.7M Q3 '23: 360.2M Q4 '23: 357.7M Q1 '24: 354.7M Q2 '24: 367.8M Q3 '24: 391.2M Q4 '24: 390.4M Q1 '25: 341.9M Q2 '25: 339.6M Q3 '25: 321.8M Q4 '25: 319.6M Q1 '26: 359.5M Q2 '26: 355.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

0 30M 60M 90M Q3 '21: 68.1M Q4 '21: 82.5M Q1 '22: 83.6M Q2 '22: 74.9M Q3 '22: 76.9M Q4 '22: 64.2M Q1 '23: 62.9M Q2 '23: 58.3M Q3 '23: 56.8M Q4 '23: 54.3M Q1 '24: 54.2M Q2 '24: 56.8M Q3 '24: 61.7M Q4 '24: 62.4M Q1 '25: 52.5M Q2 '25: 52.6M Q3 '25: 49.2M Q4 '25: 48.7M Q1 '26: 57.9M Q2 '26: 57.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 500M 1B 1.5B Q3 '21: 750.5M Q4 '21: 773.2M Q1 '22: 863.6M Q2 '22: 1B Q3 '22: 1.1B Q4 '22: 1.2B Q1 '23: 1.1B Q2 '23: 971.4M Q3 '23: 875.5M Q4 '23: 803.3M Q1 '24: 784.2M Q2 '24: 790.7M Q3 '24: 722.1M Q4 '24: 717M Q1 '25: 718M Q2 '25: 734.7M Q3 '25: 784.1M Q4 '25: 818.8M Q1 '26: 847.2M Q2 '26: 849.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

0 200M 400M 600M Q3 '21: 419.1M Q4 '21: 408.4M Q1 '22: 357.8M Q2 '22: 347M Q3 '22: 363M Q4 '22: 463.7M Q1 '23: 503.8M Q2 '23: 481.5M Q3 '23: 466.9M Q4 '23: 452M Q1 '24: 411.7M Q2 '24: 435.1M Q3 '24: 460.2M Q4 '24: 485M Q1 '25: 426.2M Q2 '25: 313.4M Q3 '25: 292.6M Q4 '25: 280.5M Q1 '26: 344.9M Q2 '26: 465.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

0 200M 400M 600M Q3 '21: 372.8M Q4 '21: 327.3M Q1 '22: 269.1M Q2 '22: 260.8M Q3 '22: 274.9M Q4 '22: 409.6M Q1 '23: 457.4M Q2 '23: 442.5M Q3 '23: 424.3M Q4 '23: 405.2M Q1 '24: 367.8M Q2 '24: 385.5M Q3 '24: 411.9M Q4 '24: 436M Q1 '25: 371.1M Q2 '25: 244M Q3 '25: 209.1M Q4 '25: 201.7M Q1 '26: 276.5M Q2 '26: 409.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

EPS TTM

0.00 0.50 1.00 1.50 Q3 '15: 1.38 Q4 '15: 1.47 Q3 '15 Q4 '15

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.